000276102 001__ 276102
000276102 005__ 20250314091251.0
000276102 0247_ $$2doi$$a10.5772/intechopen.1003993
000276102 037__ $$aDZNE-2025-00183
000276102 041__ $$aEnglish
000276102 1001_ $$aAdelaja Osibote, Otolorin$$b0$$eEditor
000276102 245__ $$aRecent Advances of Copper-64 Based Radiopharmaceuticals in Nuclear Medicine
000276102 260__ $$bIntechOpen$$c2024
000276102 29510 $$aAdvances in Dosimetry and New Trends in Radiopharmaceuticals / Adelaja Osibote, Otolorin (Editor) ; : IntechOpen, , Chapter 5 ; ISBN: 978-0-85466-008-7 ; doi:10.5772/intechopen.110965
000276102 300__ $$a1 - 24
000276102 3367_ $$2ORCID$$aBOOK_CHAPTER
000276102 3367_ $$07$$2EndNote$$aBook Section
000276102 3367_ $$2DRIVER$$abookPart
000276102 3367_ $$2BibTeX$$aINBOOK
000276102 3367_ $$2DataCite$$aOutput Types/Book chapter
000276102 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book$$bcontb$$mcontb$$s1738662662_26729
000276102 520__ $$aCopper radioisotopes including copper-60/61/62, and -64 exhibit a wide range of decay characteristics, making them appropriate choices for diagnostic/therapeutic (theranostic) applications in nuclear medicine. One notable feature of copper is the feasible coordination chemistry, which makes radiolabeling of a wide range of chemical structures including antibodies, proteins, peptides, and other biologically relevant small molecules possible. This chapter will summarize common radiopharmaceuticals of copper-64 and their radiation dosimetry in order to highlight recent improvements of positron emission tomography diagnostics.
000276102 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000276102 588__ $$aDataset connected to CrossRef Book
000276102 7001_ $$aEppard, Elisabeth$$b1$$eEditor
000276102 7001_ $$aVahidfar, Nasim$$b2
000276102 7001_ $$aBakhshi Kashi, Mohsen$$b3
000276102 7001_ $$aAfshar, Saeed$$b4
000276102 7001_ $$aSheikhzadeh, Peyman$$b5
000276102 7001_ $$aFarzanefar, Saeed$$b6
000276102 7001_ $$aSalehi, Yalda$$b7
000276102 7001_ $$aDelpasand, Ebrahim$$b8
000276102 7001_ $$0P:(DE-2719)9002180$$aMolloy, Eóin N.$$b9
000276102 7001_ $$aMirzaei, Siroos$$b10
000276102 7001_ $$aAhmadzadehfar, Hojjat$$b11
000276102 7001_ $$aEppard, Elisabeth$$b12
000276102 773__ $$a10.5772/intechopen.1003993
000276102 8564_ $$uhttps://pub.dzne.de/record/276102/files/DZNE-2025-00183.pdf$$yOpenAccess
000276102 8564_ $$uhttps://pub.dzne.de/record/276102/files/DZNE-2025-00183.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000276102 909CO $$ooai:pub.dzne.de:276102$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000276102 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002180$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000276102 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000276102 915__ $$0LIC:(DE-HGF)CCBY3$$2HGFVOC$$aCreative Commons Attribution CC BY 3.0
000276102 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000276102 9201_ $$0I:(DE-2719)1311001$$kAG Maaß$$lMultimodal Neuroimaging$$x0
000276102 980__ $$acontb
000276102 980__ $$aVDB
000276102 980__ $$aUNRESTRICTED
000276102 980__ $$aI:(DE-2719)1311001
000276102 9801_ $$aFullTexts